We previously reported that CS (
chondroitin sulfate) GAG (
glycosaminoglycan), expressed on MCSP (
melanoma-specific CS
proteoglycan), is important for regulating
MT3-MMP [membrane-type 3
MMP (
matrix metalloproteinase)]-mediated human
melanoma invasion and gelatinolytic activity in vitro. In the present study, we sought to determine if CS can directly enhance MT3-MMP-mediated activation of
pro-MMP-2. Co-immunoprecipitation studies suggest that MCSP forms a complex with
MT3-MMP and MMP-2 on
melanoma cell surface. When
melanoma cells were treated with betaDX (p-nitro-beta-D-xylopyranoside) to inhibit coupling of CS on the core
protein, both active form and proform of MMP-2 were no longer co-immunoprecipitated with either MCSP or
MT3-MMP, suggesting a model in which CS directly binds to MMP-2 and presents the
gelatinase to
MT3-MMP to be activated. By using
recombinant proteins, we determined that
MT3-MMP directly activates
pro-MMP-2 and that this activation requires the interaction of the C-terminal domain of
pro-MMP-2 with
MT3-MMP. Activation of
pro-MMP-2 by suboptimal concentrations of
MT3-MMP is also significantly enhanced in the presence of excess C4S (chondroitin 4-sulfate), whereas C6S (chondroitin 6-sulfate) or low-molecular-mass
hyaluronan was ineffective. Affinity chromatography studies using CS isolated from
aggrecan indicate that the catalytic domain of
MT3-MMP and the C-terminal domain of MMP-2 directly bind to the GAG. Thus the direct binding of
pro-MMP-2 with CS through the C-domain would present the catalytic domain of
pro-MMP-2 to
MT3-MMP, which facilitates the generation of the active form of MMP-2. These results suggest that C4S, which is expressed on tumour cell surface, can function to bind to
pro-MMP-2 and facilitate its activation by MT3-MMP-expressing tumour cells to enhance invasion and
metastasis.